These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 2726652)

  • 1. Bioavailability of elcatonin (ASU1,7-eel calcitonin) after intranasal administration to rats and dogs.
    Manzoni C; Monti C; Valente M
    Pharmacol Res; 1989; 21(1):105-6. PubMed ID: 2726652
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibitory effect of [Asu1 . 7]-eel calcitonin on glucagon-induced glycogenolysis in perfused rat liver.
    Mine T; Kimura S; Ogata E
    Horm Metab Res; 1983 Mar; 15(3):139-43. PubMed ID: 6303930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of the bioavailability of intranasal elcatonin in humans: development of a sandwich transfer enzyme immunoassay for elcatonin.
    Kohno T; Murasugi N; Sakurai H; Watabe K; Nakamuta H; Koida M; Sugie Y; Ogouchi T; Inoue T; Yanaka M; Nomura M; Yanagawa A
    J Clin Lab Anal; 1998; 12(6):356-62. PubMed ID: 9850187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzyme immunoassay for elcatonin, a synthetic analogue of eel calcitonin, in plasma.
    Aikawa R; Ohyama K; Mori E; Hironaka K; Miyake M; Morishita M
    J Pharm Sci; 1985 Mar; 74(3):300-3. PubMed ID: 2409265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved nasal bioavailability of elcatonin by insoluble powder formulation.
    Ishikawa F; Katsura M; Tamai I; Tsuji A
    Int J Pharm; 2001 Aug; 224(1-2):105-14. PubMed ID: 11472819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced rectal absorption of [Asu1,7]-eel calcitonin in rats using polyacrylic acid aqueous gel base.
    Morimoto K; Akatsuchi H; Aikawa R; Morishita M; Morisaka K
    J Pharm Sci; 1984 Oct; 73(10):1366-8. PubMed ID: 6502483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of the pulmonary absorption of (Asu1,7)-eel calcitonin by various protease inhibitors in rats.
    Morita T; Yamamoto A; Takakura Y; Hashida M; Sezaki H
    Pharm Res; 1994 Jun; 11(6):909-13. PubMed ID: 7937534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovariectomy-induced hyperalgesia and antinociceptive effect of elcatonin, a synthetic eel calcitonin.
    Shibata K; Takeda M; Ito A; Takeda M; Sagai H
    Pharmacol Biochem Behav; 1998 Jun; 60(2):371-6. PubMed ID: 9632219
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The bioavailability of intranasal salmon calcitonin in healthy volunteers with and without a permeation enhancer.
    Lee WA; Ennis RD; Longenecker JP; Bengtsson P
    Pharm Res; 1994 May; 11(5):747-50. PubMed ID: 8058647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bimodal action of [Asu1,7]eel-calcitonin on phosphoinositide hydrolysis in cultured anterior pituitary cells.
    Sortino MA; Canonico PL; Clementi G
    Eur J Pharmacol; 1991 Aug; 207(4):345-50. PubMed ID: 1664337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of intracerebroventricular administration of rat calcitonin gene-related peptide (CGRP), human calcitonin and [Asu1,7]-eel calcitonin on gastric acid secretion in rats.
    Okimura Y; Chihara K; Abe H; Kaji H; Kita T; Kashio Y; Fujita T
    Endocrinol Jpn; 1986 Apr; 33(2):273-7. PubMed ID: 3489610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic effects of carbocalcitonin and salmon calcitonin, after endonasal administration in man.
    Cecchettin M; Segre G
    Biomed Pharmacother; 1995; 49(4):215-8. PubMed ID: 7669941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced bioavailability of calcitonin formulated with alkylglycosides following nasal and ocular administration in rats.
    Ahsan F; Arnold J; Meezan E; Pillion DJ
    Pharm Res; 2001 Dec; 18(12):1742-6. PubMed ID: 11785695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of drug delivery systems for a therapeutic agent used in osteoporosis. I. Pharmacodynamics (hypocalcemic effect) of elcatonin in rabbits following rectal administration of hollow-type suppositories containing elcatonin.
    Watanabe Y; Mizufune Y; Kubomura A; Kiriyama M; Utoguchi N; Matsumoto M
    Biol Pharm Bull; 1998 Nov; 21(11):1187-90. PubMed ID: 9853410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antihypertensive action of elcatonin].
    Takayanagi N; Tozuka T; Toda N
    Nihon Yakurigaku Zasshi; 1983 Nov; 82(5):383-93. PubMed ID: 6671629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rectal absorption of [Asu1,7]-eel calcitonin in rats.
    Miyake M; Nishihata T; Nagano A; Kyobashi Y; Kamada A
    Chem Pharm Bull (Tokyo); 1985 Feb; 33(2):740-5. PubMed ID: 4017120
    [No Abstract]   [Full Text] [Related]  

  • 17. Stability of [Asu1,7]-eel calcitonin and eel calcitonin in vitro and in vivo.
    Yamauchi H; Shiraki M; Otani M; Matsuo M; Orimo H
    Endocrinol Jpn; 1977 Jun; 24(3):281-5. PubMed ID: 913338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of non-ionic surfactants in a polyacrylic acid gel base on the rectal absorption of [Asu1,7]-eel calcitonin in rats.
    Morimoto K; Akatsuchi H; Morisaka K; Kamada A
    J Pharm Pharmacol; 1985 Oct; 37(10):759-60. PubMed ID: 2867154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution and metabolism of [Asu1,7]-eel calcitonin in isolated perfused rat pancreas.
    Iwakawa S; Komada F; Okumura K; Hori R
    Chem Pharm Bull (Tokyo); 1984 Apr; 32(4):1546-50. PubMed ID: 6380780
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of (Asu1,7)E-CT, synthetic analogue of eel-calcitonin, on nociceptive transmission.
    Clementi G; Amico-Roxas M; Caruso A; Fiore CE; Trombadore S; Scapagnini U
    Pharmacol Res Commun; 1985 Oct; 17(10):967-73. PubMed ID: 2999838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.